From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

The Great ShareProphets Christmas Red Flags At Night Sweepstakes Is Back – Place Your Bets Now

By Rachel From Customer Services | Saturday 21 December 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As I ponder the best way to kindle economic growth, I have come up with a cunning plan: taxing dodgy RNSs at no-one-is-watching o’clock on Christmas Eve. That’s sure to work. My friend Diane Abbot reckons if I charge a very reasonable and affordable £1 million per dodgy RNS on Christmas Eve on these rich companies which pay little tax – largely on the AIM tax-avoidance market - it will bring in trillions, especially if last year’s total of 46 is repeated. They have to pay their fair share, after all. As an internationally recognised economist, I think we have to take these numbers seriously.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 19:04:22